StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TECX

Tectonic Therapeutic, Inc.

TECX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$29.35
+0.18 +0.62%

Key statistics

from XBRL data in SEC filings
Market cap
$554M
Revenue (TTM)
Net income (TTM)
-$74.2B
EPS (TTM)
$-4.46
P/E ratio
Dividend yield
Free cash flow
-$60.3M
Cash
$237M
Total assets
$247M
Gross margin
52-week range
$14.39 – $39.53

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results; Other events Jun 10, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change; Regulation FD disclosure Apr 23, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Director or officer change; Regulation FD disclosure Feb 24, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Shareholder vote results Jun 6, 2025 8-K Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 3, 2025 8-K Regulation FD disclosure; Other events Jan 30, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure Sep 19, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Regulation FD disclosure; Other events Jul 30, 2024 8-K Director or officer change Jul 5, 2024 8-K Regulation FD disclosure; Other events Jun 26, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Unregistered sale of equity; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06; Other events Jun 20, 2024 8-K/A Other events Jun 18, 2024 8-K Other events Jun 14, 2024 8-K Shareholder vote results Jun 11, 2024 8-K Other events Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K Regulation FD disclosure Jan 30, 2024 8-K Entered a material agreement; Change in control; Director or officer change; Regulation FD disclosure Jan 30, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 10, 2023